Hydrochloric Acid → 2-[(2-Methyl-4-morpholinyl)methyl]-N-(6-{6-(methyloxy)-5-[(methylsulfonyl)amino]-3-pyridinyl}-1H-indazol-4-yl)-1,3-thiazole-4-carboxamide

HRID 1695788Notes

Reaction equation

Cl[CH2:2][C:3]1[S:4][CH:5]=[C:6]([C:8]([NH:10][C:11]2[CH:19]=[C:18]([C:20]3[CH:21]=[N:22][C:23]([O:31][CH3:32])=[C:24]([NH:26][S:27]([CH3:30])(=[O:29])=[O:28])[CH:25]=3)[CH:17]=[C:16]3[C:12]=2[CH:13]=[N:14][N:15]3S(C2C=CC=CC=2)(=O)=O)=[O:9])[N:7]=1.[CH3:42][CH:43]1[O:48][CH2:47][CH2:46][NH:45][CH2:44]1.[OH-].[Na+].Cl>CS(C)=O.CC(O)C>[CH3:42][CH:43]1[O:48][CH2:47][CH2:46][N:45]([CH2:2][C:3]2[S:4][CH:5]=[C:6]([C:8]([NH:10][C:11]3[CH:19]=[C:18]([C:20]4[CH:21]=[N:22][C:23]([O:31][CH3:32])=[C:24]([NH:26][S:27]([CH3:30])(=[O:28])=[O:29])[CH:25]=4)[CH:17]=[C:16]4[C:12]=3[CH:13]=[N:14][NH:15]4)=[O:9])[N:7]=2)[CH2:44]1

Participants

Conditions

Temperature: 90 °C

Procedure

2-(Chloromethyl)-N-[6-{6-(methyloxy)-5-[(methylsulfonyl)amino]-3-pyridinyl}-1-(phenylsulfonyl)-1H-indazol-4-yl]-1,3-thiazole-4-carboxamide (50 mg, 0.079 mmol) was added to 2-methylmorpholine (0.5 ml, 0.079 mmol). The reaction mixture was heated in the microwave for 15 min at 90° C. The solvent was blown off under nitrogen. IPA (2 ml) and 2M NaOH (2 ml) were added to the mixture. The reaction mixture was stirred for 30 hours, then neutralised with 2M HCl aqueous to pH 7. The solvent was blown off under nitrogen. The mixture was dissolved in 2 ml of DMSO. Insoluble matter was removed by filtration and purification was carried out by MDAP (Method E) to afford the title compound (5 mg).

Workup

customInsoluble matter was removed by filtration and purification

Sources & evidence

ORD record: ord-78e03e3fbdc14f84ba9f9a10ee11064e
Source dataset: uspto-grants-2012_04
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US08163743B2

Reaction notes

Loading…